These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23583259)

  • 21. Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design.
    Lansdon EB; Brendza KM; Hung M; Wang R; Mukund S; Jin D; Birkus G; Kutty N; Liu X
    J Med Chem; 2010 May; 53(10):4295-9. PubMed ID: 20438081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of human and mouse pregnane X receptor agonistic activity in 200 pesticides using in vitro reporter gene assays.
    Kojima H; Sata F; Takeuchi S; Sueyoshi T; Nagai T
    Toxicology; 2011 Feb; 280(3):77-87. PubMed ID: 21115097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane X receptor.
    Lau AJ; Yang G; Rajaraman G; Baucom CC; Chang TK
    Drug Metab Dispos; 2012 Jan; 40(1):178-86. PubMed ID: 22019630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor.
    Sharma M; Saravolatz LD
    J Antimicrob Chemother; 2013 Feb; 68(2):250-6. PubMed ID: 23099850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Discovery and development of diarylpyrimidines (DAPYs) as next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
    Tian XT; Xie L
    Yao Xue Xue Bao; 2010 Feb; 45(2):177-83. PubMed ID: 21351427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rilpivirine: a second-generation nonnucleoside reverse transcriptase inhibitor.
    James C; Preininger L; Sweet M
    Am J Health Syst Pharm; 2012 May; 69(10):857-61. PubMed ID: 22555080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies.
    Anta L; Llibre JM; Poveda E; Blanco JL; Alvarez M; Pérez-Elías MJ; Aguilera A; Caballero E; Soriano V; de Mendoza C;
    AIDS; 2013 Jan; 27(1):81-5. PubMed ID: 22842995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes.
    Rulcova A; Prokopova I; Krausova L; Bitman M; Vrzal R; Dvorak Z; Blahos J; Pavek P
    J Thromb Haemost; 2010 Dec; 8(12):2708-17. PubMed ID: 20735727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro.
    Weiss J; Haefeli WE
    Int J Antimicrob Agents; 2013 May; 41(5):484-7. PubMed ID: 23428312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein phosphatase 2Cbetal regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.
    Pondugula SR; Tong AA; Wu J; Cui J; Chen T
    Drug Metab Dispos; 2010 Sep; 38(9):1411-6. PubMed ID: 20538721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors.
    Lapadula G; Calabresi A; Castelnuovo F; Costarelli S; Quiros-Roldan E; Paraninfo G; Ceresoli F; Gargiulo F; Manca N; Carosi G; Torti C
    Antivir Ther; 2008; 13(4):601-5. PubMed ID: 18672539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic parameters of once-daily rilpivirine following administration of efavirenz in healthy subjects.
    Crauwels H; Vingerhoets J; Ryan R; Witek J; Anderson D
    Antivir Ther; 2012; 17(3):439-46. PubMed ID: 22293086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Ginkgo biloba as a novel activator of pregnane X receptor.
    Yeung EY; Sueyoshi T; Negishi M; Chang TK
    Drug Metab Dispos; 2008 Nov; 36(11):2270-6. PubMed ID: 18725505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz.
    Blas-García A; Polo M; Alegre F; Funes HA; Martínez E; Apostolova N; Esplugues JV
    J Antimicrob Chemother; 2014 Nov; 69(11):2995-3000. PubMed ID: 25011651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Environmental phthalate monoesters activate pregnane X receptor-mediated transcription.
    Hurst CH; Waxman DJ
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):266-74. PubMed ID: 15364542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4: investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines.
    Vrzal R; Kubesova K; Pavek P; Dvorak Z
    Toxicol Lett; 2010 Mar; 193(2):183-8. PubMed ID: 20080160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nigramide C is a natural agonist of human pregnane x receptor.
    Kanno Y; Yatsu T; Li W; Koike K; Inouye Y
    Drug Metab Dispos; 2014 Jun; 42(6):1084-9. PubMed ID: 24705672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.
    Nicot F; Saliou A; Raymond S; Sauné K; Dubois M; Massip P; Marchou B; Delobel P; Izopet J
    J Clin Virol; 2012 Oct; 55(2):107-13. PubMed ID: 22818969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability.
    Usach I; Melis V; Peris JE
    J Int AIDS Soc; 2013 Sep; 16(1):1-14. PubMed ID: 24008177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pregnane X receptor agonist with unique species-dependent stereoselectivity and its implications in drug development.
    Mu Y; Stephenson CR; Kendall C; Saini SP; Toma D; Ren S; Cai H; Strom SC; Day BW; Wipf P; Xie W
    Mol Pharmacol; 2005 Aug; 68(2):403-13. PubMed ID: 15872116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.